Genpharmasec Share Price | Genpharmasec Stock Screener
GENPHARMA
Trading & Distributors
Share Price BSE
₹1.05
▲
0.03 (2.94%)
As of July 20, 2026, the Genpharmasec share price (BSE: GENPHARMA) is ₹1.05, up 2.94% from the previous close, with shares trading between ₹1.01 and ₹1.05, and a 52-week range of ₹0.78–₹2.06.
Analyse Genpharmasec stock price data download and track historical price performance.
Use the Genpharmasec stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Genpharmasec Market Cap
₹59.79 Cr.
GENPHARMA P/E Ratio (TTM)
112.00
Genpharmasec P/B Ratio
0.94
EPS (TTM)
₹0.01
Dividend Yield
-
Debt to Equity
0.07
GENPHARMA 52 Week High
₹2.06
Genpharmasec 52 Week Low
₹0.78
Operating Margin
4.00%
Profit Margin
1.75%
GENPHARMA Revenue (TTM)
₹57.00
EBITDA
₹3.00
Net Income
₹1.00
Total Assets
₹138.00
Total Equity
₹66.00
Genpharmasec Share Price Chart
Screen Genpharmasec share price with an interactive chart. Analyse GENPHARMA price trends and volatility across different timeframes.
Genpharmasec Company Profile - Fundamental Screener
Screen Genpharmasec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GENPHARMA shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE861N01036
Genpharmasec Balance Sheet Screener
Screen GENPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 138 | 80 | 71 | 20 |
| Current Assets | 81 | 27 | 41 | 19 |
| Fixed Assets | 23 | 8 | 1 | 0 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 26 | 5 | 4 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 66 | 65 | 65 | 15 |
| Share Capital | 55 | 55 | 55 | 28 |
| Reserves & Surplus | 11 | 10 | 9 | -12 |
Genpharmasec Income Statement Screener - Profit & Revenue Analysis
Screen Genpharmasec income statement and profit fundamentals.
Analyze GENPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Genpharmasec share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57 | 15 | 13 | 33 | 41 | 11 | 6 | 7 | 9 | 6 | 6 | 8 | 7 |
| Expenses | 53 | 15 | 11 | 33 | 41 | 10 | 5 | 6 | 8 | 6 | 6 | 8 | 6 |
| EBITDA | 3 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 0 |
| Operating Profit % | 4.00% | -7.00% | 8.00% | -1.00% | -3.00% | 0.00% | 4.00% | 2.00% | 8.00% | 3.00% | 0.00% | -1.00% | 0.00% |
| Depreciation | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 0 | 1 | -1 | -1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Tax | 1 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 1 | -1 | 0 | 0 | 0 |
| Net Profit | 1 | 0 | 1 | -1 | -1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| EPS | 0.02 | -0.01 | 0.02 | -0.02 | -0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.00 | 0.00 | 0.00 |
Genpharmasec Cash Flow Screener - Liquidity Fundamentals
Screen GENPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 3 | -3 | -3 |
| Investing Activities | -15 | -28 | 0 |
| Financing Activities | -1 | 48 | 3 |
| Net Cash Flow | -14 | 17 | 0 |
Genpharmasec Shareholding Pattern Screener
See Genpharmasec shareholding pattern with promoter, FII, and DII holdings.
Check Genpharmasec promoter holding and ownership changes for GENPHARMA on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 61.86% | 59.94% | 60.03% | 60.19% | 62.00% | 52.78% | 56.17% | 61.26% |
| Other Holding | 8.16% | 10.08% | 9.99% | 9.83% | 8.02% | 17.24% | 13.84% | 8.76% |
| Shareholder Count | 102,252 | 109,080 | 107,602 | 105,804 | 104,021 | 105,693 | 108,137 | 108,220 |
Genpharmasec Share Dividend Screener - Share Yield Analysis
Check Genpharmasec dividend history with payout and yield data.
View Genpharmasec dividend details including ex-dates and amounts for GENPHARMA stock.
Genpharmasec Stock Index Membership
See which indices include Genpharmasec stock.
Check GENPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Genpharmasec Market Events Screener - Corporate Actions
Get Genpharmasec corporate actions including splits, bonuses, and buybacks.
Check Genpharmasec stock events that may affect GENPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | -3.36% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | -2.59% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -11.30% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 1.04% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-21 | 2025-05-21 | Quarterly Result Announcement | NA | 9.27% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -11.46% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -6.05% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 10.55% |
| 2024-01-09 | 2024-01-09 | Rights | 1:1 | 82.23% |
| 2021-09-06 | 2021-09-06 | Change Of Name | NA | 0.00% |
Genpharmasec Competitors Screener - Peer Comparison
Screen GENPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 22,148 | 17.06 | 119,347 | 19.87% | 1,284 | 64.52 |
| MMTC | 9,743 | 25.24 | 1 | -99.46% | 550 | 42.87 |
| MSTC | 4,623 | 21.60 | 370 | -4.60% | 221 | 53.95 |
| Ravindra Energy | 3,469 | 42.78 | 543 | 107.17% | 84 | 64.79 |
| Elitecon International | 3,194 | 10.04 | 551 | 55040.00% | 70 | 15.25 |
| BN Agrochem | 2,777 | 80.89 | 873 | 137.82% | 17 | 47.62 |
| Vintage Coffee & Beverages | 2,410 | 32.56 | 553 | 76.98% | 72 | 61.91 |
| TCC Concept | 1,596 | 23.48 | 179 | 100.21% | 31 | 47.81 |
| Creative Newtech | 1,410 | 18.12 | 2,700 | 49.86% | 70 | 86.14 |
| RRP Defense | 942 | -912.11 | 12 | 17.90% | -1 | 12.96 |
Genpharmasec Company Announcements - News Screener
Screen GENPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-27 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-21 | Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St March 2026. | - |
| 2026-05-21 | Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended 31St March 2026. | - |
| 2026-05-21 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday May 21 2026. | - |
| 2026-05-13 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 21St May 2026. | - |
| 2026-04-14 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-03-24 | Outcome Of Separate Meeting Of Independent Directors Of The Company. | - |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-09 | Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St December 2025. | - |
| 2026-02-09 | Unaudited Standalone & Consolidated Financial Result Of The Company For The Quarter Ended December 31 2025. | - |
| 2026-02-09 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Monday February 09 2026. | - |
| 2026-02-02 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday 09Th February 2026. | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-26 | Closure of Trading Window | - |
| 2025-11-11 | Submission Of Clear Copy Of Financial Results For The Quarter And Half Year Ended September 30 2025. | - |